Verrill et al., 1977 - Google Patents
Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.Verrill et al., 1977
View PDF- Document ID
- 951554442624286275
- Author
- Verrill H
- Pickard N
- Gruemer H
- Publication year
- Publication venue
- Clinical chemistry
External Links
Snippet
Above-normal plasma enzyme activities resulting from increased release of intracellular macromolecules are an important diagnostic feature of Duchenne muscular dystrophy. These and other biochemical and histological characteristics of this disease are faithfully …
- 102000004190 Enzymes 0 title abstract description 44
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1199883A (en) | Assessment of nutritional status of individuals | |
Greaves et al. | Immunosuppressive potency and in-vitro activity of antilymphocyte globulin | |
Mowat et al. | Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis | |
Cohen et al. | Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects | |
Jones et al. | Subcellular distribution and mobilization of MAC-1 (CD11b/CD18) in neonatal neutrophils | |
Eastman et al. | Distinctions between idiopathic ineffective erythropoiesis and di Guglielmo’s disease: clinical and biochemical differences | |
MX2007007326A (en) | Suspension medium for red blood cells. | |
Rieder et al. | Hemoglobin Zürich: clinical, chemical and kinetic studies | |
Scott et al. | Erythropoietic protoporphyria with features of a sideroblastic anaemia terminating in liver failure | |
Gavin et al. | Evidence that iron stores regulate iron absorption—a setpoint theory | |
Anderson et al. | Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients | |
ELSAS et al. | Wilson's Disease with reversible renal tubular dysfunction: Correlation with proximal tubular ultrastructure | |
Verrill et al. | Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability. | |
Lewis et al. | Hypercupremia associated with a monoclonal immunoglobulin | |
McMillan et al. | Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura | |
AGGERBECK et al. | Hypobetalipoproteinemia: Clinical and biochemical description of a new kindred with ‘Friedreich” s ataxia' | |
Hakala et al. | Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract | |
Lind et al. | Observations on blood glucose and insulin determinations | |
FROELICH et al. | A case of Guillain-Barre syndrome with immunologic abnormalities | |
Werre et al. | Causes of macroplania of erythrocytes in diseases of the liver and biliary tract with special reference to leptocytosis | |
White et al. | Platelet spherocytosis: a new bleeding disorder | |
Nakashima et al. | Red cell density in various blood disorders | |
Rokkones et al. | Congenital renal dysplasia, retinal dysplasia and mental retardation associated with hyperprolinuria and hyper‐OH‐prolinuria | |
Lane et al. | Defective energy metabolism in stored granulocytes | |
Kantor et al. | Cytomegalovirus infection associated with cardiopulmonary bypass |